Assessment of Metabolic & Path Response w/ RCT & ImT Before Surgery in Locally Advanced Esoph and Gastro-esoph Jction CA

Conditions:   Adenocarcinoma of the Esophagus;   Adenocarcinoma of the Gastroesophageal Junction;   Squamous Cell Carcinoma of the Esophagus
Interventions:   Drug: Monalizumab;   Drug: Oxaliplatin;   Drug: 5-Fluorouracil;   Radiation: Metabolic;   Other: Metabolic;   Procedure: Surgery
Sponsors:   Jules Bordet Institute;   Innate Pharma
Recruiting

http://ift.tt/2xBcnMM